Thursday, October 29, 2009

Simplicity

I am beginning to think that my machine diagram is easy to understand. My concern is that it is overly simplistic. I mean essentially the "device" I am analyzing is a tissue engineered scaffold for ACL replacement. I am focusing on one of these scaffolds which is described in an article entitled "Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation." The design of this scaffold focuses on architecture, porosity, degradability, and cell source. Architecture covers the amount of surface area. While porosity also covers the amount of surface area, it additionally involves the pore diameter. Both surface area and pore diameter function to encourage the body's ability to accept the new ACL scaffold and generate new cells. PLAGA is the biodegradable material being used to create the fibers in the scaffold. It is imperative that the fibers degrade over time and the body does not treat them as foreign materials. Biocompatibility is essential. The cell source primarily focuses on the body's cellular response. This device has not been used in humans, but rabbit ACL cells as well as mouse fibroblasts were put on the scaffold under lab conditions that simulated body conditions to see the potential for cell migration and attachment. In other words, to see if more cells were generated and to see how they moved along the scaffold.

The PLAGA fibers get braided together using 3-D braiding methods in either a circular or rectangular geometry. These entwined fibers get tested on their mechanical properties such as tensile modulus, or tendency to be deformed when a force is applied, and , maximum tensile load, or the maximum force the device can take before certain areas deform due to disproportionate amount of force and stress. The scaffold had 3 regions all made of the same PLAGA fibers, but these fibers were braided at different angles. The regions were the "femoral tunnel attachment site, ligament region, and tibial tunnel attachment site" (Copper et. al., 2004). A higher angle was used at the ends that would be attached to bone, while a lower angle was used for the ligament region. Bones are not flexible like ligaments, which explains the use of the higher angle to enable healing. After writing this, I guess my device is not as simple as I thought. I think this should be a good paper.

Sunday, October 25, 2009

how does this work: a preliminary machine diagram















(The only way I could figure out putting the diagram into the post was literally printing it out, taking a picture of it, and uploading the picture. I could not paste it from a word or powerpoint file.)
The top left to right says: Architecture, Porosity, Degradability, Cell Source; Force, Regeneration of cells (mass).
The middle left to right says: Knee; Cells (Mass) ; PLAGA fibers.
The bottom left to right says: Knee strength and stability; Body’s ability to accept new ACL scaffold and generate, Cell migration and attachment; 3-D braiding geometry, Circular or rectangular, Biomaterial of fiber, PLGA, Braiding angle, Pore diameter, Surface area.

I found creating a machine diagram for an ACL tissue scaffold quite difficult. I am wondering whether the first component should be the knee or something else. Essentially, the scaffold is just fibers twisted together. It does not really have several "components." Here's my first attempt at a machine diagram (with the knee as component one). This is subject to change if I have some moment of genius in which I discover a more appropriate component one.

The issue at hand is that my machine is more abstract than a more mechanical device like an artificial arm. I think the item being transferred for my device is cells, although it really seems like it is the potential for the regrowth of cells. I guess an exercise like this does not have one right answer. Problems sometimes have different types of solutions that can lead to the same end result. In my project that concept is at play. Different people have studied different methods of construction ACL tissue scaffolds in terms of biomaterial used, angle the material is braided at, the pore size of the fibers, and such. They all use different methods that lead to the end result of an ACL tissue scaffold. Sure the strengths may be slighltly different, but the overall solution is to create the tissue scaffold and try to minimize recovery time while improving the current ACL reconstruction methods used.

Wednesday, October 21, 2009

focus, focus, focus

So after all that reading, note taking, quoting, and searching I have come up with my final questions.

1. Why do we need to use tissue engineering for ACL scaffolding?
  • background on injury rates, number of surgeries performed annually
  • why does the ACL not heal on its own?
  • problems with past and current methods of treatment- allograft, autograft, prosthesis- commercial ones (Carbon Fiber Prostheses, Gore Tex, Darcon, Leeds-Keio Artificial Ligament, Kennedy Ligament Augmentation)
  • more specific- why do women have a higher risk of tearing their ACLs?
2. What components will be used?
  • Use design from "Fiber-based tissue-engineered scaffold for ligament replacement:
    design considerations and in vitro evaluation
    James A. Cooper a,b,c,d, Helen H. Luf, Frank K. Koe, Joseph W. Freemana,
    Cato T. Laurencin a,b,c,d,*"
  • Polymeric fibers of polyactide-co-glycolide 10:90 (PLGA fibers)
  • Biodegradable materials
  • 3-D braiding technology
  • Braiding geometry
  • TABLE 1- effects of braiding geometry on other parameters- "Results from the porosimetry analyses of the PLAGA
    circular and rectangular braided scaffolds are summarized
    in Table 1. The effects of braiding geometry on the
    linear density, mode pore diameter, median pore
    diameter, surface area, braiding angle, and porosity of
    the scaffolds can be derived from Table 1."
  • Braiding angle
  • Advantages of this design- controlled pore diameter promote tissue infiltration throughout scaffold, custom design with 3-D braiding, 3-D braiding prevents catastrophy from one tiny break
3. How does it work?
  • design from Cooper et. al.
  • Surgical implant, instead of the basically 2 procedures using an autograft (remove tissue from one area and put it in ACL), only one (just put in new scaffold)
  • Architecture
  • Porosity
  • Degradability
  • Cell Source
  • IDEAL "The ideal ACL replacement scaffold should be
    biodegradable, porous, biocompatible, exhibit sufficient
    mechanical strength, and able to promote the formation
    of ligamentous tissue." from article mentioned above
  • 3 regions- "The objective
    was to design a scaffold that provides the newly
    regenerating tissue with a temporary site for cell
    attachment, proliferation, and mechanical stability. As
    shown in Fig. 1, the 3-D braided scaffold was comprised
    of three regions: femoral tunnel attachment site,
    ligament region, and tibial tunnel attachment site. The
    attachment sites had high angle fiber orientation at the
    bony attachment ends and lower angle fiber orientation
    in the intraarticular zone. This pre-designed heterogeneity
    in the grafts was aimed to promote the eventual
    integration of the graft with bone tissue. The scaffold
    was composed of PLAGA fiber with diameter similar to
    that of type I collagen fiber."
  • Cell adhesion
  • Cells spread across fiber
  • Cell migration and attachment
4. What will the strength be?
  • evaluating the design described in Cooper et. al.
  • ultimate tensile strengths tested- "The ultimate tensile strengths ranged
    from ~100 to 400 MPa"
  • circular geometry was stronger than rectangular - "When the same number of yarns was
    used for the rectangular and circular braids the circular
    braid geometry showed a significant increase in maximum
    tensile load. The 3-D circular fibrous scaffold was
    able to withstand tensile loads of 907N (SD7132 N),
    which was greater than the level for normal human
    physical activity that is estimated to range between 67
    and 700N"
  • Table 2- Maximum loads and ultimate tensile strength


5. How can it be improved?
  • keep going with design from Cooper et. al.
  • optimal braiding angle, pore size, biocompatibility
  • "Future studies will focus on the scaffold’s initial
    mechanical properties as compared to a rabbit model
    and in vitro characterization of the cellular response and
    interaction with the braided tissue-engineered ligament
    scaffold."

Tuesday, October 20, 2009

Useful slides on ACL

http://www.nytimes.com/slideshow/2007/08/01/health/100230Anteriorcruciateligamentrepairseries_index.html

Anterior Cruciate Ligament Repair (ACL)


"The anterior cruciate ligament (ACL) is a ligament in the center of the knee that prevents the shin bone (tibia) from moving forward on the thigh bone (femur)."

"If the ACL is torn, the knee joint may become unstable and affect the ability to perform work or athletic activities."

"ACL reconstruction is surgery to replace the torn ACL ligament. There are several choices of tissue to use for the new ligament, including an autograft (tissue from the patient’s own body) or an allograft (tissue from a cadaver). One of the most common autografts use part of the patellar tendon (the tendon in the front of the knee)."
-that's also the surgery I had along with repairing a medial meniscus


"The old ligament is removed using a shaver or other instruments. Bone tunnels are made to place the new ligament (patellar graft) in the knee at the site of the old ACL. Screws are commonly used to secure the graft in the bone tunnels, although other methods of fixation are used depending on the type of graft used."

"At the end of the surgery, the incisions are closed, and a dressing is applied. ACL reconstruction is usually a very successful surgery. The majority of patients will have a stable knee that does not give way after ACL reconstruction."
-really majority of patients do have a stable knee, but not like it was before as supported by statistics in other science journals

The Uneven Playing Field

http://www.nytimes.com/2008/05/11/magazine/11Girls-t.html

This is my favorite article. It does not deal with the specifics of tissue engineering for ACLs, but it deals with the higher proportion of female ACL tears than male as well as female athletes' mentalities versus males' mentalities. The article gives a more human aspect to the issue.

  • WHY NEED TISSUE ENGINEERING- "But among all the sports injuries that afflict girls and young women, A.C.L. tears, for understandable reasons, get the most attention. No other common orthopedic injury is as debilitating and disruptive in the short term — or as likely to involve serious long-term consequences. And no other injury strikes women at such markedly higher rates or terrifies them as much."
  • WHY NEED TISSUE ENGINEERING- "AN A.C.L. DOES NOT tear so much as it explodes, often during routine athletic maneuvers — landings from jumps, decelerations from sprints — that look innocuous until the athlete crumples to the ground. After the A.C.L. pulls off the femur, it turns into a viscous liquid. The ligament cannot be repaired; it has to be replaced with a graft, which the surgeon usually forms by taking a slice of the patellar tendon below the kneecap or from a hamstring tendon. One reason for the long rehabilitation is that the procedure is really two operations — one at the site of the injury and the other at the donor site, where the tendon is cut."
  • WOMEN AT RISK- "female athletes rupture their A.C.L.’s at rates as high as five times that of males."
  • ISSUE HYPOTHETICAL EXAMPLE WOMEN AT RISK- "So imagine a hypothetical high-school soccer team of 20 girls, a fairly typical roster size, and multiply it by the conservative estimate of 200 exposures a season. The result is 4,000 exposures. In a cohort of 20 soccer-playing girls, the statistics predict that 1 each year will experience an A.C.L. injury and go through reconstructive surgery, rehabilitation and the loss of a season — an eternity for a high schooler. Over the course of four years, 4 out of the 20 girls on that team will rupture an A.C.L."
  • MORE THAN INJURY-"Each of them will likely experience “a grief reaction,” says Dr. Jo Hannafin, orthopedic director of the Women’s Sports Medicine Center at the Hospital for Special Surgery in New York. “They’ve lost their sport and they’ve lost the kinship of their friends, which is almost as bad as not being able to play.”
  • WOMEN AT RISK DUE TO BIOMECHANICS- "“Women tend to be more erect and upright when they land, and they land harder,” he [Steve Marshall, a professor at the University of North Carolina’s School of Public Health, who leads a large A.C.L. study financed by the National Institutes of Health that is following students at the three major U.S. military academies] said. “They bend less through the knees and hips and the rest of their bodies, and they don’t absorb the impact of the landing in the same way that males do. I don’t want to sound horrible about it, but we can make a woman athlete run and jump more like a man.”"
  • SERIOUS FEMALE ATHLETE PSYCHE- "JANELLE’ HIGH SCHOOL, St. Thomas Aquinas, is the alma mater of the tennis immortal Chris Evert and the former football star Michael Irvin. It places a high value on attracting and developing young athletes, and on keeping them healthy enough to go on and play in college. “I get more compliance from the boys,” the school’s athletic trainer, Dwayne Owens, told me. “Boys are actually willing to sit if that’s what I tell them. The girls want to get back out there. They want me to tape them up and let them play.” I repeatedly heard similar sentiments from doctors, coaches and others: Girls are more likely to put themselves at risk. If they’ve played through a lot of pain in the past, they may be inured to it."
  • USE THIS EXAMPLE IN INTRODUCTION TO GRAB ATTENTION-
  • Amy Stedman- "In her junior year in high school, in Brevard, N.C., Parade magazine named her the top high-school-age defensive player in America, “the best of the best.” She was a captain of the U.S. women’s under-19 team, a future star of the women’s national team. She played for Anson Dorrance at U.N.C., and while I was talking to him one day, he pointed out beyond his office door to a gallery where the uniforms of his all-time greats, including Mia Hamm, were displayed. “She would have been one of those jerseys out there,” he said, referring to Amy."
  • "But by the time I met her, Amy was 21 and had torn the A.C.L. in her right knee four times. The first time was when she was training for the under-19 World Cup."
  • "As Amy walked toward me the first time we met, her right leg was stiff and her whole gait crooked. She moved like a much older woman. If I hadn’t known her history, I would never have believed she had been an athlete, let alone an elite one. She had undergone, by her count, five operations on her right knee. Her mother counted eight, and believed that Amy did not put certain minor cuttings in the category of actual operations. She was done playing. She had been told she would need a knee replacement, maybe by the time she turned 30."
  • "Amy told me about her final operation, recalling that when she came out of anesthesia, the surgeon seemed as if he was going to cry. He looked at her in silence for what seemed like a long time, trying to compose himself. Finally, he told her, “Amy, there was nothing in there left to fix.”"
  • FEMALE ATHLETE PSYCHE: "That was still Janelle’s mind-set: Rehab hard. Get back on the field. Compete fiercely. And hope not to be injured."

Role of biomechanics in the understanding of normal, injured, and healing ligaments and tendons

http://www.ncbi.nlm.nih.gov/pubmed/19457264

  • WHY NEED TISSUE ENGINEERING- "It is also known that a midsubstance anterior cruciate ligament (ACL) tear has limited healing capability, and reconstruction by soft tissue grafts has been regularly performed to regain knee function. However, long term follow-up studies have revealed that 20–25% of patients experience unsatisfactory results."
  • WHY NEED TISSUE ENGINEERING- "Well over 100,000 of these procedures are done per year in the U.S. alone [13]. However, long term follow-up studies have revealed that 20–25% of patients experience unsatisfactory results at 7 to 10 years following ACL reconstruction"
  • FUNCTION- "Because the primary function of ligaments and tendons is
    to transmit tensile forces, experimental studies of the biomechanical
    properties of these tissues are generally performed
    in uniaxial tension... tensile tests have been performed with the ligament
    or tendon insertions to bone left anatomically intact"
  • HOW TO MEASURE AREA- "developed to measure both the cross-sectional area
    and the shape of soft tissues with high accuracy and precision"
  • FUNCTION- "Additionally, since ligaments and tendons are highly
    organized fibrous tissues, their mechanical properties are
    directionally dependent (anisotropic)."
  • FUNCTION-"Mathematical models have been made to describe the viscoelastic
    properties of ligaments and tendons."
  • PROPERTY- "Age-related changes are one biological factor worth discussing"
  • FUNCTION- "The properties of ligaments and tendons also can change
    with advancing age as well as with activity level"
  • WHY ACL DOES NOT HEAL- "Unlike extraarticular
    ligaments, there exist several well known factors that
    limit the ACL from healing [178,179]. The thin synovium
    surrounding the ACL, which has been shown to play an
    important role in providing a vascular supply to the relatively
    avascular ACL as well as to protect it from the harsh
    synovial fluid [180], is disrupted and not regenerated
    until 1 to 2 months following ACL injury [175,181-183].
    Histological examination of the human ACL reveals that
    it is also retracted following rupture and that clots formed
    are insufficient to fill the open gap"
  • CURRENT OPTIONS- "Surgical replacements have been done
    for a large percentage of patients to help maintain knee
    stability [196-200]. Autografts, such as the bone-patellar tendon-bone (BPTB) and hamstring tendons, and allografts
    are the graft of choice... 20–25% unsatisfactory results, with complaints
    such as knee pain and extension deficits [78,201-204],
    and most concerning, many of these cases had progressed
    to knee osteoarthritis"
  • TEST- "To assess the function of the ACL under multiple degree of
    freedom (DOF) knee motion, our research center has
    developed a robotic/universal force moment sensor (UFS)
    testing system since 1993 (Figure 4) [218]. This novel testing
    system can control and reproduce the multiple DOF
    knee motion [38,40,41,219-221] and is also capable of
    applying external loads to knees. By operating in both force
    and position control modes, the robot can apply a predetermined
    external load to the specimen, such as those
    used for the diagnosis of ACL deficiency"
  • COMPUTER MODELS- "Computational finite element models are also valuable for
    studying for the complex function of the ACL and its bundles.
    Once such models are validated with experimental
    data (e.g., knee kinematics or in-situ forces as determined
    using the robotic/UFS testing system [227,228]), they can
    be used to calculate the stress and strain distribution in the
    ACL, by incorporating its non-uniform geometry (in which
    the midsubstance cross-sectional area is one-third that of
    the insertions) and its twisting fiber orientation."
  • TISSUE ENGINEERING COULD LEAD TO BETTER RESULTS- "The use of growth factors, gene
    therapy, cell therapy, and biological scaffolds to enhance
    healing certainly will result in improved outcomes
    [61,242-247]. We believe the ECM-derived bioscaffolds
    will play a significant role because it could accelerate the
    healing process and establish a bridge between the torn
    ends."

The phenotypic responses of human anterior cruciate ligament cells cultured on poly(-caprolactone) and chitosan

http://www3.interscience.wiley.com/journal/117935006/grouphome/home.html
probably only use for background too specific
  • PURPOSE OF THIS STUDY- "The purpose of this study is to evaluate the phenotypic responses of human anterior cruciate ligament (ACL) cells on two biodegradable materials: poly(-caprolactone) (PCL) and chitosan"
  • CHITOSAN- "Chitosan is a deacetylated product of chitin that is a plentiful polysaccharide found in nature and is safe for the human body. It was reported that this material could accelerate the wound healing and stimulate the macrophage releasing lots of growth factors to promote ECM production"
  • PCL- "poly(-caprolactone) (PCL) is a synthetic and semi-crystalline linear -polyester and has been used as an implantable material for a long time."
  • FDA APPROVED- "Both PCL and chitosan are biodegradable and have been approved by Food and Drug Administration (FDA)"
  • bad results for chitosan adhesion, better for PCL specific numbers in article- "After 4 h of adhesion, cell number on PCL (48,800 � 4100) and chitosan (17,900 � 5300) showed a significant difference... After incubation for 3 days, cell growth was observed on both substrates. The cell number on PCL and chitosan increased to 91,100 � 16,700 and 29,000 � 4100, respectively" (the symbol thing is plus or minus)
  • NEED- "Therefore, a substrate with the activity to promote cell adhesion and ECM production is very valuable."
  • SUPPORT CHITOSAN AS SCAFFOLD- "These results support the chitosan as scaffold for ACL tissue engineering, which can stimulate ACL cells to synthesize more quantity of FN and TGF 1 proteins."

Biomimetic Stratified Scaffold Design for Ligament-to-Bone Interface Tissue Engineering

http://www.ncbi.nlm.nih.gov/sites/entrez

  • ABSTRACT- "Biological fixation will require re-establishment of the structure-function relationship inherent at the native
    soft tissue-to-bone interface on these tissue engineered grafts. To this end, strategic biomimicry must be incorporated into
    advanced scaffold design."
  • ADVANCES- "Significant advances have thus been
    made in the development of ligament- [1-7], tendon- [8-13],
    cartilage-[14-24] and bone-like [25-34] tissues by combining
    cells and biomaterials along with biochemical and/or biophysical
    stimulation"
  • TISSUE TO TISSUE INTERFACE- "Therefore,
    the development of integrated musculoskeletal tissue
    systems will require not only the re-establishment of the inherent
    structure-function relationship of each type of tissue,
    but also the concurrent regeneration of the complex tissueto-
    tissue interface."
  • MULTI-PHASE SCAFFOLD-" It is anticipated that the formation of integrated tissue
    systems similar to those observed at the junctions between
    orthopaedic soft and hard tissues will require a multi-phased
    scaffold which supports the growth and differentiation of
    multiple cell types."
  • PROBLEM WITH TENDON ACL RECONST.- "While
    tendon-based ACL reconstruction grafts may restore the
    physiological range of motion through mechanical fixation,
    biological fixation is not achieved. In the absence of an anatomical
    interface, the graft-bone junction exhibits poor mechanical
    stability [56-58] and this remains the primary cause
    of graft failure"
  • UNDERSTAND MATERIAL PROPERTIES- "In the paradigm for functional tissue engineering outlined
    by Butler et al., [37] significant emphasis is placed on understanding
    the material properties of the tissue to be replaced,
    as well as quantifying the in vivo strains and stresses experienced
    by the native tissue under physiological loading."
  • 3 REGIONS OF TISSUES IN ACL- "three distinct tissue regions are found at the ACL-bone insertion site: ligament, fibrocartilage, and bone. The fibrocartilage
    region is further divided into non-mineralized fibrocartilage
    and mineralized fibrocartilage regions"
  • DESIGN MORE THAN 1 TYPE OF TISSUE NEEDS TO BE ABLE TO REGENERATE- "Thus interface scaffold design
    must consider the need to regenerate more than one type of
    tissue"
  • STRUCTURE-FUNCTION PERSPECTIVE
  • REGIONAL TENSION- "when the joint is loaded in tension, the deformation
    across the insertion site is region-dependent, with the
    highest displacement found at the ACL, then decreasing in
    magnitude from the fibrocartilage interface to bone"
  • COW STATS ACL REGION- "bovine ACL-bone interface,
    the compressive modulus of the non-mineralized fibrocartilage
    region was 0.32 ± 0.14 MPa [71], which is more
    than 50% lower than that of the mineralized fibrocartilage
    region which averaged 0.68 ± 0.39 MPa [71]. Both of these
    values are lower than that of trabecular bone which is reported to be 173 ± 97 MPa in the neonatal bovine model"
  • FIGURE 1 Biomimetic Stratified Scaffold Design for Ligament-to-Bone Interface Tissue Engineering
  • STRATEGY TO ENGINEER MECH. INHOMOGENITY IN SCAFFOLD- "one strategy to engineer controlled mechanical
    inhomogeneity on the interface scaffold is by regulating the
    distribution and concentration of calcium phosphate on the
    scaffold phases."
  • LAYERED SCAFFOLD- "a stratified scaffold is required
    to recapitulate the multi-tissue organization observed at the
    native ligament-to-bone interface"
  • CHALLENGE B/C DIFFERENT TISSUE TYPES IN ACL- "The multi-tissue transition from ligament to fibrocartilage
    and to bone at the ACL-bone interface represents a significant
    challenge for functional interface tissue engineering
    as several distinct types of tissue are observed at this insertion
    site."
  • DIFF. TISSUE TYPES-"supporting the
    growth and differentiation of relevant cell populations, must
    direct heterotypic and homotypic cellular interactions while
    promoting the formation and maintenance of controlled matrix
    heterogeneity"
  • DIFF. TISSUE TYPES- "The interface scaffold must also exhibit mechanical properties
    comparable to those of the ligament-to-bone interface. In
    addition, the scaffold phases should be biodegradable so that
    it can be gradually replaced by living tissue, and the degradation
    process must be balanced with respect to the scaffold
    mechanical properties in order to permit physiological loading
    and neo-interface function."
  • STRENGTH- "strength of the ligamentous
    tissue is crucial to the success of the ACL graft"
  • FROM OTHER ARTICLE COOPER ET. AL.- "Recently, Cooper et
    al. [6] reported on a multi-phased design of a synthetic ACL
    graft with a ligament proper as well as two bony regions.
    This novel ACL scaffold was fabricated from 3-D braiding
    of polylactide-co-glycolide fibers, and scaffold porosity differed
    between the bone and ligament regions, with the extended
    goal of promoting ACL graft integration within the
    bone tunnels. In vitro [7] and in vivo [91] evaluation of this
    ACL fibroblast seeded scaffold demonstrated biocompatibility,
    healing and mechanical strength in a rabbit model. This
    new design represents a significant improvement over single-
    phased ACL grafts, and the next step is to address the
    challenge of graft integration with bone, by including the
    fibrocartilage interface in the ligament scaffold design."
  • 3 PHASE SCAFFOLD
  • tri-phasic scaffold
  • "With this scaffold design, a biomimetic
    phase-specific cell distribution was established, with osteoblasts
    and fibroblasts localized in their respective regions,
    while their interaction was restricted to Phase B, the interface
    region."
  • 3 PHASE- "While both anatomic ligament- and bone-like matrices
    were formed on the tri-phasic scaffold in vitro and in vivo,
    no fibrocartilage-like tissue was observed in the interface
    phase through osteoblast-fibroblast co-culture."
  • OPTIMAL CLINICAL OUTCOME- "The optimal clinical outcome is to have a completely mineralized tissue within the bone tunnel, accompanied by the formation
    of an anatomic fibrocartilage insertion on the soft tissue
    graft."

Tissue Engineering of the Anterior Cruciate Ligament: The Viscoelastic Behavior and Cell Viability of a Novel Braid–Twist Scaffold

http://www.ncbi.nlm.nih.gov/pubmed/19723437

  • OVERVIEW OF STUDY- "In this study we tested novel braid–
    twist scaffolds, as well as braided scaffolds, twisted fiber scaffolds and aligned fiber scaffolds, for use as ACL replacements composed of poly(L-lactic acid) fibers. Scaffolds were examined using stress relaxation tests, cell viability assays and scanning electron microscopy."
  • WHAT IS AN AUTOGRAFT AND WHAT IS AN ALLOGRAFT- "Autografts utilize tissue from the patient and allograft materials are obtained from a cadaver."
  • FUNCTION WHAT ACL DOES- "The ACL is a viscoelastic tissue with a time-dependant and load history dependant response to applied forces [10]. This is typically manifested as creep, a change in sample length at a constant stress, or stress relaxation, a decrease in
    stress at a constant length. The viscoelastic response of the tissue is typically studied
    with creep or relaxation tests at one load or strain level [10]. This behavior is
    caused by the arrangement of the collagen fibers in the ligament, interactions between
    collagen and other macromolecules in the matrix (such as proteoglycans),
    and removal of water from the matrix with applied force."
  • THEIR TECHNIQUE- "Our scaffold technique (the braid–
    twist) is designed to mimic the biomechanical properties and structure of the natural
    ligament while providing an environment conducive for cell and tissue growth."
  • PARAMETERS- "Structural parameters such as braiding and twisting angle were varied in order to optimize
    scaffold behavior. Differences in cellular proliferation between these braid–twist
    and braided scaffolds were also measured."
  • THEIR TYPES OF SCAFFOLD- "Braiding and twisting angles were varied for each type of scaffold, yielding a total of 15 types of scaffolds for testing
    (6 twisted scaffolds, 3 braided scaffolds and 6 braid–twist scaffolds)."
  • USE OF MATH MODELS 2.3 MODELING OF MECHANICAL DATA- "The mechanical behavior of the different braid–twist scaffolds were modeled with
    a linear viscoelastic model and a quasi-linear viscoelastic (QLV) model. The linear
    viscoelastic model was a series of Maxwell models, a combination of a spring and
    a dashpot. The equation for the stress at time, t , for a Maxwell model is given in
    equation (1):
    σ(t) = σ0e−t/τ , (1)
    where the stress is noted by σ and the relaxation time is τ . After placing three
    Maxwell models in series, the equation for the stress in this system at time t is
    given by equation (2):
    σ(t) = Xσ0e−t/τx + Yσ0e−t/τy +Zσ0e−t/τz , (2)
    where X, Y and Z are the contributions of the yarns, fiber bundles and fibers. The
    relaxation times of these parts are τx , τy and τz.
    The constants X, Y and Z were the same for each combination of braiding and
    twisting angle with four and six turns per inch."
  • RABBIT ACLS- "Primary patella tendon (PT) fibroblasts from female New Zealand
    white rabbits were harvested and cultured as reported earlier"
  • PROMISE OF REGENERATION OF LIGAMENTS- "In vivo studies with this 3-D braided tissue-engineered ligament (TEL) display
    the tremendous promise of this scaffold toward the functional replacement
    and regeneration of ligaments [22]."
  • WHY USE 3-D BRAIDING- "The fibers in the 3-D braiding technique all reinforce
    one another, thus increasing scaffold strength; 3-D braiding also creates a network
    of interconnected pores to aid in tissue infiltration and cell migration."
  • WHY USE BIOMATERIAL-" PLLA is a
    degradable polymer which allows load to gradually shift from the implant to the
    neoligament over time."
  • GROWTH OF ECM IN FIGURE 9- "growth of extracellular
    matrix material on both types of scaffolds over a 28-day period"
  • HOW TO IMPROVE- "Future work will focus on optimizing the stress relaxation behavior,
    investigating braid–twist scaffold porosity and optimizing the mathematical models."

Translational Studies in Anterior Cruciate Ligament Repair

http://www.liebertonline.com/doi/abs/10.1089/ten.tea.2009.0147

  • WHY NEED IT-"Recent years have shown a clearer
    definition of the clinical problem and established an underlying mechanistic cause of the incapacity of the
    anterior cruciate ligament to heal—the premature loss of provisional scaffold in the wound site. These clinical
    findings were then translated into a research objective, namely, to replace the missing scaffold with a biomaterial
    with appropriate structural and bio-stimulatory characteristics."
  • WHY NEED IT- "Current estimates of
    the prevalence of reported ACL tears range at 4.8% of ambulatory
    individuals between 50 and 90 years of age, but it is
    very likely that the actual number, including asymptomatic
    tears in patients with low demand, is even higher.2,3 The risk
    of ACL tears is significantly increased by participating in
    particular sports, especially those involving pivoting, and for
    women.4–8 ACL tears are serious injuries causing immediate
    pain and loss of mobility."
  • COLLAGEN AS BIOMATERIAL- "Among all biomaterials currently used in tissue
    engineering, collagen has a long-standing record as a biocompatible,
    biodegradable, and safe material for orthopedic
    applications and is the main constituent of the ACL"
  • COLLAGEN IN COW ACL- "Murray et al. showed that cells from human torn ACL
    migrate into a scaffold made from bovine atelocollagen (Fig. 3) and secrete smooth muscle actin, which causes
    wound contraction44,45,62 (Fig. 2). ACL fibroblasts retain this
    ability also in the ruptured ACL, where they exhibit even
    higher outgrowth rates.62"
  • WHY DOES ACL NOT HEAL- "A translational research approach helped to identify one
    potential reason why the torn ACL does not heal: the lack of a fibrin clot that stabilizes the defect and serves as a scaffold
    for cell migration and a source for stimulating factors."

reading done let the note taking begin

I read all 8 of the scientific journal articles and found out that one of them really was not that relevant to my topic (so I won't use it). The article from The New York Times Magazine literally made me cry. I guess I felt I have a similar story to several of the young women in the article. I think I may want to forget my questions on whether the treatment will ever be accepted in the US as the standard of treatment and does benefit outweigh cost. I want to incorporate why women are at higher risk for ACL tears instead of those questions. Also I have realized that a few of the articles are on different techniques of creating the artificial ligament, but share common themes of the need for biodegradable material and strength testing. I think I will zone in on when specific technique while using the other articles for background information and such. I will now proceed to blog my notes on the articles (except the one that isn't relevant to my topic).

Monday, October 19, 2009

Anterior cruciate ligament reconstruction: a look at prosthetics - past, present and possible future

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322926/

Abstract
  • "history of the use of prosthetics"
  • "Carbon Fibre, Gore-Tex and Darcon prosthetics... Leeds-Keio Artificial Ligament and the Kennedy Ligament Augmentation Device (LAD)"
Introduction
  • "(ACL) is the most
    frequently injured ligament in the knee"
  • "poor intrinsic healing ability"
  • surgical reconstruction
  • "patients who experience ACL injuries
    are significantly younger and more active than those
    who experience many other orthopaedic injuries. The
    need for reconstruction options that exhibit longevity"
  • primary repairs- fail
  • prosthetic replacements- inadequate
  • biological tissue autograft- popular
  • "ACL anatomy, tissue
    composition, biomechanics, and the healing processes.
    Unfortunately, to date, no prosthesis has proven itself as
    a viable alternative to the patellar or hamstring tendon
    autografts, currently used in over 90% of ACL
    reconstructions."
Surgical Repair
  • "Bone-patellar tendon-bone (BPTB) and
    semitendinosus/gracilis tendon autografts are currently
    the most common grafts"
  • "Both techniques
    now offer a high degree of strength and stiffness in the
    reconstructed ligament."
  • PROBLEMS W. PATELLA AND HAMSTRING GRAFT- "Nonetheless, with patellar tendon
    autografts, many patients experience impaired function
    and significant morbidity at the donor site including
    secondary anterior knee pain, patellar tendonitis,
    infrapatellar contracture, and patellar fracture.
    Likewise, hamstring weakness and saphenous nerve
    injury can be seen secondary to hamstring harvest in
    semitendinosus/gracilis autograft ACL reconstruction"
  • PROBLEMS W. DONOR(CADAVER) ACLS- "the use of
    allografts is not currently considered advantageous due
    to a limited donor tissue supply, delayed biological
    incorporation, risks of disease transmission and tissue
    rejection."
Prosthetics
  • history of ACL grafts- 1918 silk sutures fail 3 months
  • 1973 PTFE break 1 year
  • GRAFTS- "Grafts
    (polyethylene, PTFE), typically fixed at both ends, were
    the initial focus of synthetic ACL replacement and were
    meant to provide stability to the ACL-deficient-knee
    until secondary reconstruction procedures gained
    popularity (11)."
  • lig. augmentation- "Similarly, ligament augmentation
    devices (polypropylene, polyester) were intended to
    provide immediate protection for autogenous tissue
    grafts until revascularization was complete and the
    ingrown tissue was capable of withstanding local tensile
    and compressive forces."
  • total prosthesis
  • no tissue maturation
  • long-term -> poor
  • scaffold design
  • problems- "Problems associated with the biological
    incorporation of scaffolds include variability of tissue
    in-growth, immature degeneration of the implant and
    insufficient maturation of the host tissue resulting in an
    inability of the scaffold to withstand inherent
    mechanical stresses placed on the ACL."
Carbon Fiber
  • carbon fibre prostheses
  • 1977
  • "migration of carbon wear particles into
    the joint space and regional lymph nodes following
    implantation of the prosthesis"
  • coat carbon to solve
  • "Surgicraft ABC prosthetic ACL"
  • "only 11 of 31 knees (41%) had good results
    defined as a Lysholm score greater than 76."
  • ADVANTAGE DISADVANTAGE TABLE ON P. 31!!!!
Gore Tex
  • "The Gore-Tex ligament prosthesis is composed of a
    single long fiber of expanded polytetrafluoroethylene
    (PTFE) arranged into loops. Extensive mechanical
    testing has shown that the resulting ultimate tensile
    strength is about 3 times that of the human ACL and the
    results from cyclical creep tests and bending fatigue
    testing seem to identify Gore-Tex as the strongest
    synthetic ACL replacement in terms of pure material
    stability"
  • deteriorates over time
  • decreasing success rate over years
  • "90% success rate at 2 years
    versus only a 76% success rate at 3 years or more"
  • "The Gore-Tex ACL prosthesis is currently FDA
    approved for use in patients who have had a failed
    autogenous intra-articular graft procedure."
Dacron
  • "The implant is a
    composite of four tightly woven polyester strips
    wrapped in a sheath of loosely woven velour, designed
    to minimize abrasion of the graft and act as a scaffold
    for fibrous tissue ingrowth."
  • failure rate- 31.7% in 50 months
  • failure rate- 47.5% in 4 years
  • deterioration
  • NOT VIABLE
Leeds-Keio Artificial Ligament
  • "a polyester meshlike
    structure anchored to the femur and tibia with bone
    plugs (24)"
  • "The implant was considered
    sufficiently flexible to be effective with a maximal
    tensile strength of approximately 2100 Newtons (N),
    which significantly exceeds that of the average young
    adults’ natural ACL (about 1730 N)"
  • ingrowth of unaligned fibrous tissue
  • long-term show deterioration
  • NOT VIABLE
Kennedy Ligament Augmentation
  • "The graft,
    composed of a band-like braid of polypropylene, was
    originally developed to reinforce the area of pre-patellar
    tissue considered to be a weak area of autogenous
    patellar tendon grafts."
  • "Comparisons of the patellar tendon and
    semitendinosus/gracilis LAD composite grafts revealed
    that the LAD will accept approximately 28% and 45%
    of the applied load, respectively (31)."
  • attached to bone at one end only
  • collagen fibers
  • "Furthermore, as an intra-articular foreign body, the
    LAD has been reported to induce an inflammatory
    response characterized by foreign body giant cells and
    macrophages in the surrounding tissue."
  • LACK OF WIDESPREAD USE- NOT GOOD
LARS artificial ligament
  • "The Ligament Advanced Reinforcement System
    (LARS) (Arc-sur-Tille, France) artificial ligament
    consists of fibres made of polyethylene terephthalate
    (PET)."
  • knitted structure
  • fibers twisted at right angles (90 degrees)
  • mimic natural lig. structure
  • encourage tissue ingrowth b/c of porosity
  • "Thirty-eight
    of forty-seven patients suffered from chronic
    ruptures of the ACL, while nine others presented with
    acute or subacute ruptures at a mean follow-up of 21.9
    months. Six patients had previously had an
    unsuccessful ACL reconstruction."
  • Scales to test knees- Tenger activity scale, telos radioactive stress system
  • "no patients returned to pre-injury activity levels"
  • chronic instability
  • Lysholm score
  • RISK OF RUPTURE
Tissue Eng.
  • "Permanent synthetic prostheses are capable of
    duplicating the mechanical and structural properties of
    the ACL. However, they generally tend to lose strength
    with time. Tissue-based or tissue-aided implants offer
    the additional possibility of the restoration of normal
    joint kinematics while the mechanical behaviour of
    these implants is expected to improve over time as tissues are remodelled within the knee"
  • "must also degrade at a rate similar to that
    of tissue ingrowth. Accordingly, the ACL scaffold
    should lose its mechanical integrity while allowing the
    remodelled tissues to gain strength and accept an
    increasing amount of the mechanical demands placed
    on the ACL. Current research into this novel tissueengineering
    approach has focused on seeding either
    collagen-based scaffolds or synthetic biodegradable
    polymers with a variety of different cell types."
  • "rabbit fibroblasts on skin and ACL scaffolds"
  • "As an alternative to the scaffolds made of nondegradable
    polymers, investigators have begun to
    examine biodegradable materials that would provide
    immediate stabilization to the repaired ligament but
    would also act as a scaffold for the ingrowth and/or
    replacement by host cells. Cao et al. described the
    generation of neo-tendons in a nude mice model by
    implanting polyglycolic acid (PGA) scaffolds seeded
    with bovine tendon fibroblasts in the subcutaneous
    space of athymic mice"
  • PGA scaffolds
  • bone marrow stomal cells
  • "The future of tissue engineering may also require a
    significant contribution from cell-specific growth
    factors influencing the maturation and homeostasis of
    the healing response of ligament tissue."
  • "the optimal activity of each growth factor"
Computer-Assisted ACL Reconst.
  • "computer-assisted surgery in an attempt
    to reduce the incidence of graft failure"
  • "the use of computer-assisted
    ACL reconstruction may lead to similarly dramatic
    improvements in technical and functional outcomes"
CONCLUSION
  • past 30 years
  • "Most of the grafts that have been
    developed to date have failed due to unsatisfactory
    long-term physiologic and functional performance.
    Most permanent ACL prostheses are prone to creep,
    fatigue, and mechanical failure within several years
    after implantation (40). Tissue ingrowth scaffolds and
    ligament augmentation devices require further
    refinement to provide effective mechanical support
    while avoiding stress-shielding of the host tissue. In
    view of these factors, prosthetics are not widely used
    today in ACL reconstruction, and autogenous tissue
    grafts remain the gold standard used by the majority of
    surgeons."
  • FUTURE- "Advances in
    tissue engineering combined with developments in
    molecular biology and gene therapy may couple with
    the rapid gains in computer-assisted surgery to provide
    improved options for the ACL-deficient knee, with a
    greater potential to restore its pre-injury state."

Fiber-based tissue-enginered scaffold for ligament replacement: design consideration and in vitro evaluation

I am going to title each of the posts by the title of the article to make it easier for me to find notes on each article. P.S. the link for this article is posted in an older post.

Abstract
  • ACL- "most commonly injured ligament of the knee"
  • "150,000 ACL surgeries performed annually in the US"
  • "biodegradable, tissue-engineered ACL graft"
  • "construct architecture, porosity, degradability, and cell source"
  • "polymeric fibers of polyactide-co-glycolide 10:90"
  • "three-dimensional braiding technology"
Introduction
  • "over 250,000 patients each year diagnosed with a torn ACL"
  • "current treatment... bone-patellar, tendon-bone and hamstring-tendon"
  • "donor site related problems"
  • "commercially available synthetic ACL grafts... Gore Tex prosthesis, the Stryker-Dacron ligament, and the Kennedy ligament augmentation device (LAD)... long-term clinical
  • Def. tissue eng.- "Tissue engineering may be defined as the application of biological, chemical, and engineering principles toward the repair, restoration, or regeneration of living tissues using biomaterials, cells, and factors alone or in combination"
  • Ideal- "The ideal ACL replacement scaffold should be
    biodegradable, porous, biocompatible, exhibit sufficient
    mechanical strength, and able to promote the formation
    of ligamentous tissue."
  • Architecture
  • "Scaffolds developed within these
    pore size ranges will encourage tissue ingrowth, capillary
    supply, and improve the quality of anchorage in bone
    tunnels."
  • "increases the overall surface area
    for cell attachment, which in turn can enhance the
    regenerative properties"
  • Biodegradable materials
  • no foreign body reaction
  • PLGA fibers
  • ACL- 3 areas where fibers arranged- "anteromedial, posterolateral,
    and intermedial"
  • Objective-"design a scaffold
    that would provide the newly regenerating tissue a
    temporary site for cell attachment, proliferation, and
    mechanical stability."
  • Cell source and response
  • scaffold biocompatibility
Materials and Methods
  • braiding, PLAGA 10:90
  • Architecture- pore diameter, porosity, surface area
  • Mechanical properties
  • tensile strength
  • load as a function of braiding angle
  • cells and cell culture
  • scaffold in vitro evaluation
  • cell growth
  • scanning electron microscopy
  • "effects of braiding geometry ib the linear density, mode pore diameter, median pore
    diameter, surface area, braiding angle, and porosity of
    the scaffolds can be derived from Table 1."
  • surface area
  • braiding angle
  • mechanical properties
  • "differ in strength due to differences in strain rate
    and geometry"
  • "cell adhesion and spreading on the braided scaffold"
  • primary rabbit ACL cells
  • "primary ACL cells clustered and grew in small groups
    on the 3-D scaffold"
  • spread across fiber- Fig. 4
  • cell migration and attachment- Fig. 5
  • mouse 8 days- Fig. 6
  • rabbit 8 days- Fig. 7
  • Advantages- "controlled porosity
    and pore diameter to encourage tissue infiltration
    throughout the scaffold, which are lacking in most
    ACL artificial implants. The 3-D braiding system
    allowed for custom production of scaffolds with
    mechanical properties similar to those of natural
    ACL tissue in order to overcome issues of stress
    shielding during tissue ingrowth. In addition, the
    intertwining of the fibers within the 3-D braid prevents
    total catastrophic failure of the scaffold due to a small
    rupture."
  • manipulate braiding angle to inc. or dec. porosity and mode pore diameter
  • optimal pore size
  • "lower limit pore size of 100 mm
    [24,25]. A minimum pore size of 150 mm has been
    suggested in the literature for bone and 200–250 mm
    for soft tissue"
  • "optimal pore diameters of
    100–300 mm needed for in vivo tissue ingrowth"
  • PREVIOUSLY IN PAST- "Previous ligament prostheses have been made of
    flexible composites consisting of fibers that have been
    woven or braided into structures [11,14]. These scaffolds
    performed well for a short period after implantation,
    while the long-term results have been poor [11,14]. These
    composite structures were limited by poor tissue
    integration, poor abrasion resistance, and fatigue failure
    [11,14]."
  • regnerate tissue between pores
  • structural properties
  • "ultimate tensile strengths ranged
    fromB100 to 400 MPa"
  • circular better- "the circular
    braid geometry showed a significant increase in maximum
    tensile load. The 3-D circular fibrous scaffold was
    able to withstand tensile loads of 907N (SD7132 N),
    which was greater than the level for normal human
    physical activity that is estimated to range between 67
    and 700N [40–42]."
  • crimp geometry- "mimic stiffness of natural ligament"
  • pore diameters- "167 and 260 um... tissue ingrowth"
  • "biocompatibility of scaffold"
  • rabbit slower growth than mouse
  • mouse not used in future studies
  • WHY NEED TISSUE ENG.- "ACL tissue engineering is need because of past
    failures in ligament reconstruction using prostheses."
  • "parameters that must be addressed
    to produce a biocompatible tissue-engineered ligament
    replacement"
  • NIH grant

Loads of Information

I have gathered eight articles from scientific journals on my research topic. I have looked through the abstracts of each, and they all seem pretty relevant. Most of the articles were found using PubMed (including the article that I mentioned in a previous post). I also have one article from the New York Times Magazine that is relevant to my topic. So far I have only read, highlighted, and took notes on two of the articles. I will give each article it's own post in an effort to keep this semi-organized.

Thursday, October 15, 2009

More Specific Questions

I determined that I am researching tissue-engineered scaffold for ACL replacement. My core questions are below.
  1. How is it made? What are the components?
  2. Will it be as strong as a transplant ACL?
  3. How does it work and hoe can it be improved?
These questions can be grouped together as being answered by more empirical facts and data. These questions will compromise the bulk of my paper.

In addition to the questions above, I have a few questions that I will bring up in my introduction or conclusion that can be deemed more abstract questions to contrast with the concrete questions above.
  1. Will it ever be accepted in the US as a standard method of treatment?
  2. Is the cost of full development greater than the possible benefit?
  3. Why is it important to develop artificial tissue?
My points can be summarized into "CORE" ponits and "ABSTRACT" info.

CORE
  • components
  • strength
  • how does it work
  • how can it be improved
ABSTRACT
  • ever accepted in US as standard treatment
  • why develop it
  • does benefit outweigh cost
Also there are 3 major commercial ACL grafts mentioned in the article I linked from my last post. I plan to compare the research going on at Drexel, University of Virginia, and Columbia to the currently developed commercial devices.

Wednesday, October 14, 2009

ACL

I think I want to research the ACL. From an engineering perspective, the artificial tissue being worked on that could be implanted during surgery. These tissues may reduce healing time. I also want to know why the proportion of female athletes who get ACL tears is much higher than in male athletes. Some claim it is the difference in the quadracep to hamstring strength ratio in the quad. Women have weaker quads than hamstrings, whereas men's quads and hamstrings are about equal in strength.

I have a pretty cool article from PubMed Plus about an artificial ligament involving scaffolding that could be used in ACL reconstruction.

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TWB-4CVV79T-1&_user=489256&_coverDate=05%2F31%2F2005&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000022721&_version=1&_urlVersion=0&_userid=489256&md5=c3c3a23aced81c1196f3f38ac03280ae


You may have to be on the PennNetwork to read the article. It's abstract is relatively interesting. It really explains how many people are getting this debilitating injury. The article describes the overall situation as well as the specific designs of the tissue scaffolding. I do not know if the topic is too specific or not but we'll go over it tomorrow. To make it more broad I could go into all the articificial knee carilage and ligaments being developed.

If I pick this as my final topic, it will be pretty personal for me knowing what I have been through and the number of people I know who have endured the same thing. One second led to essentially one year of rehabilitation.

Some questions I have are
  1. How does it work?
  2. Why is it important?
  3. When will it be used in the US as a standard method of treatment?


http://biomed.brown.edu/Courses/BI108/BI108_2004_Groups/Group06/Group6project/Graphics/Therapy/ACL_tear.jpg
http://biomed.brown.edu/Courses/BI108/BI108_2004_Groups/Group06/Group6project/Graphics/Therapy/ACL_tear.jpg

Thursday, October 8, 2009

research

What topic should I do for a science research topic? I really do not know. Big things like what cause certain diseases can be pretty complicated. In my writing seminar the other day we watched a clip about how a baby boy got a heart transplant that did not match his blood type. The baby did not reject the heart because his immune system was not fully developed yet. His blood did not yet have antibodies. One would think that doing such an operation could be more harmful than waiting for a proper match, but it ended up working out. That's a pretty cool feat of science I must say. Although this would probably never happen on the large scale in the US due to regulations. The operation was performed quite a few years ago now and the boy is still okay. The link to the news story is below (the clip we watched was from 60 minutes).

http://www.cbsnews.com/stories/2004/03/29/60minutes/main609225.shtml

Caleb is one of 19 children who have successfully received a mismatched heart transplant at The Hospital for Sick Children in Toronto.

Analyze

Basically any structure can be analyzed on different length scales. As seen from today's recitation dresses, flowers, oranges, computers, buildings, computers, etc. can all be examined in terms of their components. I thought it was pretty interesting how many people chose to relate the structure that they were analyzing to the human body. If you think about it the human body can go from DNA to nucleus to cell to tissue to organ to organ system to body (with tons of other components in between). Even I related my structure, the napkin, to skin without thinking about the fact that this is introduction to bioengineering. It was only after the presentations today that I realized comparing my structure to a part of the human body makes a firmer relation to the field of bioengineering.

http://www.sbceo.k12.ca.us/~impact2/TeachnetArchives/projects/hamner/karen_hamner_body_sys/frontleft.jpg
http://www.sbceo.k12.ca.us/~impact2/TeachnetArchives/projects/hamner/karen_hamner_body_sys/frontleft.jpg

Friday, October 2, 2009

Skin

A napkin is like skin. The scales of the napkin (napkin, layers of napkin, dimples in napkin) can be compared to the scales of the skin (skin, layers of skin, pores in skin). The analogy is quite simple. Skin covers the human body, has layers (epidermis, dermis, hypodermis), and has pores for sweat. Skin covers practically the entire human body. The layers provide for durability and protection, almost like the layers of the napkin. The pores allow for sweat to be released, like the dimples in a napkin allow for extra absorption. The napkin can entirely cover a spill, its layers contribute to the whole, and the dimples allow for more absorption. The form of each of these structures related to the function.

http://www.web-books.com/eLibrary/Medicine/Physiology/Skin/skin01.jpg
http://www.web-books.com/eLibrary/Medicine/Physiology/Skin/skin01.jpg

Napkin Photos



Napkins

Napkins. They seem pretty simple, not too many "parts." They have components though. If you can tell by now the structure I am analyzing is the napkin. A napkin is "a square piece of cloth or paper used at a meal to wipe the fingers or lips and to protect garments, or to serve food on" according to the dictionary on my MacBook Pro.

The first length scale is the napkin (which has dimensions of 6.25 by 4.5 inches and a depth of maybe 2 millimeters). The next length scale is the layers of the napkin (the napkin has three layers 6.25 by 4.5 inches, 6.25 by 3.5 inches, and 6.25 by 3.5 inches). The final length scale is the dimples in the napkin (maybe like 2 millimeter squares).

This idea was spurred as I was eating lunch at Hill with some friends. I was trying to think of something to analyze for this blog and the structure was literally in my hand. It's so simple, but still can be measured with different length scales. Sure a napkin, may be less impressive than a building, bricks, and mortar, but it can be analyzed in the same way. I saw the napkin while eating an orange. I discovered it could be measured with different scales as I thought about it. I analyzed the various components of a napkin and described it's physical characteristics.

A napkin has to be able to absorb things like water. It can't be too thick though, then it would be a sponge. It has to be soft enough for a person to wipe their mouth with. It can't be rough like sandpaper. It has to have layers for the absorption to work. It can't be too large or too heavy. It can't be like a towel. It has to be durable, more so than a tissue. Sometimes people use napkins to wipe tables. The individual dimples in the napkin work to improve the absorption and increase the 3-D surface area to absorb more liquid.

Parts and Functions

Parts are concrete. Functions are abstract. In recitation I attempted to draw a water bottle, a USB drive, and a chalk holder without looking at the paper I was drawing on. The results: images that looked nothing like the actual things I was trying to portray. Sure there might have been some similar shapes, but far from any accurate drawing. No scale, no symmetry, no concrete similarities. If I showed the pictures to someone else, they would have no idea what that object was. I think the more patience you have the more "in the zone" you can be. I have little patience with anything artistic, but I'm sure if I was locked in a room for an hour and had to come up with a drawing of something without looking at it I could do it.

I liked the "thinking without seeing" exercise more than the "seeing without thinking" one. When I started my gozinto diagram for a bicycle I went from big picture to little picture. I ended up with a whooping twenty-six sub-components, sub-sub components, up to sub-sub-sub-sub-sub components all together. Once I did the diagram again with only 6 components I thought of the essential elements that make up a bike: frame, wheels, handlebars, gears, brake, and tires. Notice that does not include pedals or a seat (opps). When drawing a diagram of functions a bike should perform I thought of four: stable with motion, steering system, support person, and speed control. I thought of these and then thought of parts that correspond to each of these functions, such as shock absorption, handlebars, frame, and brake, gears, and pedals, respective to the above functions. I think the functions are more important than the parts, but the parts are needed for the functions.